Male Sexual Dysfunction

Primary Care - Clinics in Office Practice

Volumn 37, Issue 3, 2010, Pages 473-489

  Diaz, Victor A ^a   Close, Jeremy D ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Decreased libido; Erectile dysfunction; Hypoactive sexual desire disorder; Male sexual dysfunction; Partner; Premature ejaculation; Psychotherapy; Sexual history

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; DAPOXETINE; EMLA; FLUOXETINE; HERBACEOUS AGENT; PAROXETINE; PLACEBO; PROSTAGLANDIN E1; SERTRALINE; SILDENAFIL; TADALAFIL; TESTOSTERONE; TRAZODONE; VARDENAFIL; YOHIMBINE;

ALTERNATIVE MEDICINE; ANDROGEN THERAPY; ANORGASMIA; BEHAVIOR THERAPY; BLOOD PRESSURE; DEVICE THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG DOSE INCREASE; EJACULATION DISORDER; ERECTILE DYSFUNCTION; FIBROSIS; FUNCTIONAL ANATOMY; HEART RATE; HERBAL MEDICINE; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LIBIDO DISORDER; MALE; MALE SEXUAL DYSFUNCTION; MEDICAL HISTORY; PAIN; PARESTHESIA; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PATIENT COUNSELING; PENIS ERECTION; PENIS PROSTHESIS; PHYSICAL EXAMINATION; PREMATURE EJACULATION; PRIAPISM; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 77955501941     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2010.04.002     Document Type: Review

References (63)

1. Waldinger M.D., Berendsen H.H., Blok B.F., et al. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998, 92(2):111-118.
2. Waldinger M.D. Premature ejaculation: state of the art. Urol Clin North Am 2007, 34(4):591-599. vii-viii.
3. Godpodinoff M.L. Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther 1989, 15(2):130-134.
4. Donatucci C.F. Etiology of ejaculation and pathophysiology of premature ejaculation. J Sex Med 2006, 3(Suppl 4):303-308.
5. Nusbaum M.R., Hamilton C.D. The proactive sexual health history. Am Fam Physician 2002, 66(9):1705-1712.
6. Waldinger M.D., Zwinderman A.H., Olivier B., et al. Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J Sex Med 2005, 2(4):498-507.
7. Sotomayor M. The burden of premature ejaculation: the patient's perspective. J Sex Med 2005, 2(Suppl 2):110-114.
8. Shabsigh R. Diagnosing premature ejaculation: a review. J Sex Med 2006, 3(Suppl 4):318-323.
9. Montague D.K., Jarow J., Broderick G.A., et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004, 172(1):290-294.
10. Laumann E.O., Nicolosi A., Glasser D.B., et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviors. Int J Impot Res 2005, 17(1):39-57.
11. Waldinger M.D., Hengeveld M.W., Zwinderman A.H. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994, 151(9):1377-1379.
12. Waldinger M.D., Hengeveld M.W., Zwinderman A.H. Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br J Urol 1997, 79(4):592-595.
13. Waldinger M.D. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res 2003, 15(5):309-313.
14. McMahon C.G. Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol 1998, 159(6):1935-1938.
15. McMahon C., Kim S.W., Park N.C., et al. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med 2010, 7(1 Pt 1):256-268.
16. Pryor J.L., Althof S.E., Steidle C., et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 2006, 368(9539):929-937.
17. Busato W., Galindo C.C. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int 2004, 93(7):1018-1021.
18. Dinsmore W.W., Hackett G., Goldmeier D., et al. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU Int 2007, 99(2):369-375.
19. Palmer N.R., Stuckey B.G. Premature ejaculation: a clinical update. Med J Aust 2008, 188(11):662-666.
20. Althof S. The psychology of premature ejaculation: therapies and consequences. J Sex Med 2006, 3(Suppl 4):324-331.
21. Shindel A., Nelson C., Brandes S. Urologist practice patterns in the management of premature ejaculation: a nationwide survey. J Sex Med 2008, 5(1):199-205.
22. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Text Revision DSM-IV-TR, American Psychiatric Association, Washington, DC. 4th edition.
23. Hatzimouratidis K., Hatzichristou D. Sexual dysfunctions: classifications and definitions. J Sex Med 2007, 4(1):241-250.
24. Laumann E.O., Paik A., Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999, 281(6):537-544.
25. Hatzichristou D., Rosen R.C., Broderick G., et al. Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med 2004, 1(1):49-57.
26. Bonierbale M., Lancon C., Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin 2003, 19(2):114-124.
27. Beutel M.E., Stobel-Richter Y., Brahler E. Sexual desire and sexual activity of men and women across their lifespans: results from a representative German community survey. BJU Int 2008, 101(1):76-82.
28. Kennedy S.H., Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 2009, 29(2):157-164.
29. Weiss R.J. Effects of antihypertensive agents on sexual function. Am Fam Physician 1991, 44(6):2075-2082.
30. Fogari R., Zoppi A., Corradi L., et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 1998, 11(10):1244-1247.
31. Katz N., Mazer N.A. The impact of opioids on the endocrine system. Clin J Pain 2009, 25(2):170-175.
32. Lue T.F., Giuliano F., Montorsi F., et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2004, 1(1):6-23.
33. Li D., Zhou Z., Qing D., et al. Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction. Hum Reprod 2010, 25(2):519-527.
34. Basson R., Schultz W.W. Sexual sequelae of general medical disorders. Lancet 2007, 369(9559):409-424.
35. Harman S.M., Metter E.J., Tobin J.D., et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J Clin Endocrinol Metab 2001, 86(2):724-731.
36. Davis S.R. Should women receive androgen replacement therapy, and if so, how?. Clin Endocrinol (Oxf) 2010, 72(2):149-154.
37. Krapf J.M., Simon J.A. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Maturitas 2009, 63(3):213-219.
38. Snabes M.C., Simes S.M. Approved hormonal treatments for HSDD: an unmet medical need. J Sex Med 2009, 6(7):1846-1849.
39. Gruenewald D.A., Matsumoto A.M. Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc 2003, 51(1):101-115. [discussion: 115].
40. Anonymous NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993, 270(1):83-90.
41. Montague DK., Jarow J., Broderick GA., et al. AUA guideline on the management of erectile dysfunction: diagnosis and treatment recommendations. American Urological Association Education and Research, Inc 2005, Elsevier, New York (NY).
42. Feldman H.A., Goldstein I., Hatzichristou D.G., et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994, 151(1):54-61.
43. Bella A., Lue T. Male sexual dysfunction. Smith's general urology 2008, 589-610. Lange/McGraw-Hill, New York. 17th edition. E. Tanagho (Ed.).
44. Miller T.A. Diagnostic evaluation of erectile dysfunction. Am Fam Physician 2000, 61:95-104. 109-10.
45. Tsertsvadze A., Yazdi F., Fink H.A., et al. Diagnosis and treatment of erectile dysfunction. Evidence report/technology assessment no.171 (prepared by the University of Ottawa Evidence-based Practice Centre (UO-EPC) under contract no. 290-02-0021) 2009, AHRQ publication no. 08(09)-E016, Agency for Healthcare Research and Quality, Rockville (MD).
46. Seftel A.D., Miner M.M., Kloner R.A., et al. Office evaluation of male sexual dysfunction. Urol Clin North Am 2007, 34:463-482.
47. Manolis A., Doumas M. Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications. J Hypertens 2008, 26:2074-2084.
48. Steggall M.J. Erectile dysfunction: physiology, causes and patient management. Nurs Stand 2007, 21(43):49-56.
49. Goldstein I., Lurie A.L., Lubisich J.P. Bicycle riding, perineal trauma, and erectile dysfunction: data and solutions. Curr Urol Rep 2007, 8:491-497.
50. Asplund C., Barkdull T., Weiss B.D. Genitourinary problems in bicyclists. Curr Sports Med Rep 2007, 6:333-339.
51. Makhlouf A., Kparker A., Niederberger C.S. Depression and erectile dysfunction. Urol Clin North Am 2007, 34:565-574.
52. Jankowski J.T., Seftel A.D., Strohl K.P. Erectile dysfunction and sleep related disorders. J Urol 2008, 179:837-841.
53. Rosen R.C., Riley A., Wagner G., et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49:822-830.
54. Rosen R.C., Althof S.E., Giuliano F. Research instruments for the diagnosis and treatment of patients with erectile dysfunction. Urology 2006, 68(Suppl 3A):6-16.
55. Jackson G. The importance of risk factor reduction in erectile dysfunction. Curr Urol Rep 2007, 8:463-466.
56. Hatzimouratidis K., Hatzichristou D.G. Looking to the future for erectile dysfunction therapies. Drugs 2008, 68:231-250.
57. Jang D.J., Lee M.S., Shin B.C., et al. Red ginseng for treating erectile dysfunction: a systematic review. Br J Clin Pharmacol 2008, 4:444-450.
58. Kim T.H., Jeon S.H., Hahn E.J., et al. Effects of tissue-cultured mountain ginseng (Panax ginseng CA Meyer) extract on male patients with erectile dysfunction. Asian J Androl 2009, 3:356-361.
59. Shamsa A., Hosseinzadeh H., Molaei M., et al. Evaluation of Crocus sativus L. (saffron) on male erectile dysfunction: a pilot study. Phytomedicine 2009, 16(8):690-693.
60. Zenico T., Cicero A.F., Valmorri L., et al. Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial. Andrologia 2009, 41(2):95-99.
61. Jeon J.H., Shin S., Park D., et al. Fermentation filtrates of Rubus coreanus relax the corpus cavernosum and increase sperm count and motility. J Med Food 2008, 3:474-478.
62. Meyer J.J., Rakuambo N.C., Hussein A.A. Novel xanthones from Securidaca longepedunculata with activity against erectile dysfunction. J Ethnopharmacol 2008, 3:599-603.
63. Lee M.S., Shin B.C., Ernst E. Acupuncture for treating erectile dysfunction: a systematic review. BJU Int 2009, 3:366-370.